Silorane: The Low-Shrink Composite
On this page
Direct answer
Silorane attacks polymerisation shrinkage at the monomer level: its molecules combine a siloxane backbone with oxirane rings that open during cationic polymerisation, and the volume the rings gain as they uncoil nearly cancels the volume the forming network loses — yielding shrinkage below 1 per cent, against 2 to 4 per cent for conventional methacrylates. Marketed as Filtek Silorane, the material required its own two-step self-etch adhesive, since silorane chemistry is incompatible with methacrylate bonding systems. Laboratory and clinical studies confirmed low shrinkage and good marginal integrity, but adoption stalled — the material was later withdrawn from most markets, and it survives in examinations as the definitive proof that shrinkage is a chemistry problem, not just a technique problem.
What you must remember
- Name and structure: silorane = siloxane + oxirane; ring-opening cationic polymerisation contrasts with the free-radical addition of methacrylates.
- Headline number: volumetric shrinkage under 1 per cent — commonly reported around 1 per cent or slightly below — versus 2 to 4 per cent for conventional composites.
- Mechanism: epoxy-like ring opening expands molecular span while polymerisation contracts it; the two nearly cancel, and the cationic cure also shows minimal oxygen inhibition.
- Dedicated adhesive: a silorane-specific two-step self-etch system was mandatory; methacrylate adhesives do not bond the material, a classic exam discriminator.
- Handling differences: slower-setting cationic chemistry with different finishing and repair behaviour; repair of silorane with methacrylate composite is unreliable.
- Evidence position: laboratory shrinkage and marginal integrity advantages confirmed; randomised clinical trials showed performance comparable to — not dramatically superior to — good methacrylate composites.
- Commercial fate: withdrawn from most markets, which examiners may frame as "why did low shrink alone not win?" — answer: handling, cost, system exclusivity and incremental technique already controlling shrinkage adequately.
Why a great monomer did not conquer the market
The intellectual case was airtight. If shrinkage stress is the composite restoration's chief physical flaw, and if increments, liners and ramped curing are merely damage control for a chemistry that must contract, then a monomer that barely contracts removes the disease instead of treating it. Silorane's ring-opening polymerisation delivered exactly that in laboratory testing: marginal gaps far smaller than methacrylates in high C-factor cavities, less cuspal deflection, low water sorption from the hydrophobic siloxane core. Clinical trials followed and showed restorations performing well — but well in the way the best methacrylates were already performing, because by then incremental technique, bulk-fill stress chemistry and reliable adhesives had narrowed the everyday gap.
The lessons compound. A proprietary adhesive locked practices into one system. The cure chemistry handled differently under clinical tempo. And shrinkage, it turned out, was only one of several survival variables — wear, polishability, repairability, and the operator's skill among them. The viva-ready formulation is that silorane proved the principle that polymerisation shrinkage is chemically negotiable, and its withdrawal proved that a material must win on more than one property to displace an ecosystem.
Where students slip
The first error is chemical: describing silorane polymerisation as free-radical. It is cationic ring-opening — and the corollary students miss is the reduced oxygen-inhibited layer, which changes both the placement handling and the repair story. The second error is adhesive: pairing silorane with a standard methacrylate bonding agent "because bonding agents are interchangeable" — the material demands its own system, and mismatched pairs fail at the interface. The third is evidential: claiming silorane clinical results were superior, when the honest summary is comparable performance with confirmed low shrinkage. Indian university questions tend to ask this as "classification of composites by polymerisation chemistry" or a direct short note on silorane, and the candidate who writes the under-1-per-cent figure, the ring-opening mechanism and the dedicated adhesive requirement has covered the three marks that separate grades.
Frequently asked questions
What is silorane in composite chemistry?
A hybrid monomer combining a hydrophobic siloxane backbone with oxirane rings, polymerised by cationic ring-opening to achieve shrinkage under about 1 per cent.
Why does silorane shrink so little?
Ring opening expands the reacting molecules at the same time the network formation contracts, and the two effects nearly cancel volumetrically.
Can silorane be used with ordinary methacrylate adhesives?
No — it requires its dedicated two-step self-etch silorane adhesive; methacrylate systems do not bond to its chemically different surface.
How did silorane perform clinically?
Randomised clinical trials showed good marginal integrity and performance comparable to leading methacrylate composites, confirming the low-shrinkage benefit without dramatic survival superiority.
Why did silorane disappear from most markets?
Proprietary handling requirements, cost and the fact that technique and bulk-fill chemistry had already tamed shrinkage clinically left it without a decisive advantage.